| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032555653 |
| P356 | DOI | 10.1007/S10120-015-0510-3 |
| P698 | PubMed publication ID | 26100130 |
| P2093 | author name string | Kosei Hirakawa | |
| Masakazu Yashiro | |||
| Masaichi Ohira | |||
| Tatsunari Fukuoka | |||
| Hiroaki Kasashima | |||
| Naoshi Kubo | |||
| Haruhito Kinoshita | |||
| Tamami Morisaki | |||
| Katsunobu Sakurai | |||
| Go Masuda | |||
| P2860 | cites work | A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression | Q24314451 |
| Matrix crosslinking forces tumor progression by enhancing integrin signaling | Q24646370 | ||
| Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases | Q28139317 | ||
| Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects | Q28200181 | ||
| Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell | Q28208372 | ||
| A molecular role for lysyl oxidase in breast cancer invasion | Q28216721 | ||
| RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 | ||
| Elastic fiber homeostasis requires lysyl oxidase-like 1 protein | Q28240976 | ||
| Lysyl oxidase mediates hypoxic control of metastasis | Q28271667 | ||
| Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy | Q28276295 | ||
| Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase | Q28279434 | ||
| Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells | Q28568824 | ||
| Metalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase | Q29544584 | ||
| Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma | Q30493513 | ||
| Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas | Q30544282 | ||
| LOXL as a target to increase the elastin content in adult skin: a dill extract induces the LOXL gene expression | Q33250251 | ||
| Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures | Q33943363 | ||
| Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo | Q34187677 | ||
| Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas. | Q34207894 | ||
| Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling | Q34729819 | ||
| Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells | Q35134466 | ||
| Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation | Q35239845 | ||
| Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. | Q35746400 | ||
| Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis | Q36081321 | ||
| Lysyl oxidase, extracellular matrix remodeling and cancer metastasis | Q36284915 | ||
| Notch signaling mediates hypoxia-induced tumor cell migration and invasion | Q36609130 | ||
| Upregulated expression of LOX is a novel independent prognostic marker of worse outcome in gastric cancer patients after curative surgery | Q36621104 | ||
| Hypoxia-inducible factors: central regulators of the tumor phenotype | Q36701590 | ||
| Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer | Q36866279 | ||
| LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis | Q36903532 | ||
| Three-dimensional context regulation of metastasis | Q37111021 | ||
| The tumor microenvironment and metastatic disease | Q37187529 | ||
| Immunohistochemical detection of changes in tumor hypoxia | Q37188441 | ||
| MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro. | Q37233956 | ||
| Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer | Q38965504 | ||
| Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways | Q38989588 | ||
| Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration | Q39247251 | ||
| Transcriptional profiling identifies upregulated genes following induction of epithelial-mesenchymal transition in squamous carcinoma cells | Q39431215 | ||
| Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment | Q39659310 | ||
| Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. | Q39696387 | ||
| Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells | Q39741655 | ||
| Tumor suppressive effect of lysyl oxidase proenzyme | Q39857576 | ||
| Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas | Q39971722 | ||
| Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole | Q40195317 | ||
| Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. | Q40514759 | ||
| Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice | Q41257371 | ||
| LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition. | Q41957208 | ||
| The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. | Q42831276 | ||
| Lysyl oxidase-like protein from bovine aorta. Isolation and maturation to an active form by bone morphogenetic protein-1. | Q43783344 | ||
| Identification of silencing of nine genes in human gastric cancers. | Q44220770 | ||
| Hypoxic cervical cancers with low apoptotic index are highly aggressive. | Q45128481 | ||
| Lysyl oxidase expression in bronchogenic carcinoma. | Q46406027 | ||
| Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism | Q46853176 | ||
| Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. | Q54596208 | ||
| Expression of a hypoxia-associated protein, carbonic anhydrase-9, correlates with malignant phenotypes of gastric carcinoma | Q84501443 | ||
| Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells | Q85486101 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 431-442 | |
| P577 | publication date | 2015-06-23 | |
| P1433 | published in | Gastric Cancer | Q15724608 |
| P1476 | title | Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia | |
| P478 | volume | 19 |
| Q41977476 | Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis |
| Q61454345 | Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells |
| Q90172102 | Effect of Hypoxia on Gene Expression in Cell Populations Involved in Wound Healing |
| Q55276271 | Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase. |
| Q89587251 | Gastric Tumor Microenvironment |
| Q61447507 | Identification of potential biomarkers of lung adenocarcinoma brain metastases via microarray analysis of cDNA expression profiles |
| Q58764034 | Inhibition of lysyl oxidase expression by dextran sulfate affects invasion and migration of gastric cancer cells |
| Q37631469 | Lysyl Oxidase and the Tumor Microenvironment |
| Q49177437 | Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells |
| Q92666152 | Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma |
| Q38937873 | Lysyl oxidase isoforms in gastric cancer. |
| Q89701164 | MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway |
| Q55318272 | Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. |
| Q55318093 | Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions. |
| Q61804904 | TBL1 is required for the mesenchymal phenotype of transformed breast cancer cells |
| Q47205727 | The fibrotic tumor stroma |
| Q99350038 | Transcriptional analysis of cleft palate in TGFβ3 mutant mice |
| Q36369565 | Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer |
Search more.